GREEN CROSS

green-cross-logo

Green Cross continues to build on a long legacy of providing life-saving and life-sustaining specialty therapeutics. Their bioscience division began its business in 1971 as producing plasma-derived biotherapies for the first time in Korea. For more than 40 years, they have specialized in providing biotherapeutics to improve the quality of life for people with rare and serious diseases worldwide. Their vaccine business develops and produces paediatric and adult vaccine against a broad range of in... fectious diseases, from worldโ€™s 3rd hepatitis B vaccine to quadrivalent influenza vaccine. With their mission to improve health and well-being of people around the world, they have gone down a path that nobody wishes to explore. Their extensive research and development of innovative medicines that support treatment and prevention as well as cures for diseases in a wide range of therapeutic areas demonstrate their ongoing commitment to all people who rely on their products.

#People #Financial #Website #More

GREEN CROSS

Social Links:

Industry:
Biotechnology Health Care Sustainability

Founded:
1969-11-01

Address:
Yongin, Ch'ungch'ong-namdo, South Korea

Country:
South Korea

Website Url:
http://www.greencross.com

Total Employee:
1001+

Status:
Active

Contact:
+82312609300

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Content Delivery Network Font Awesome Domain Not Resolving Apache Mobile Non Scaleable Content



Current Advisors List

chris-knoblanche_image

Chris Knoblanche Member of the Board of Directors @ Green Cross
Board_member

Current Employees Featured

mikhail-gorbachev_image

Mikhail Gorbachev
Mikhail Gorbachev Founder @ Green Cross
Founder

Founder


mikhail-gorbachev_image

Mikhail Gorbachev

Stock Details


Company's stock symbol is KRX:006280

Acquisitions List

Date Company Article Price
2016-05-08 HALO BioSynthesis Laboratories HALO BioSynthesis Laboratories acquired by Green Cross N/A

Investments List

Date Company Article Money raised
2020-10-12 Kanaph Therapeutics Green Cross investment in Series B - Kanaph Therapeutics 21 M USD
2018-11-20 Vuno Green Cross investment in Series B - Vuno 12 M USD
2018-11-20 Genoplan Green Cross investment in Series B - Genoplan 1000 K USD
2018-06-29 Genoplan Green Cross investment in Series B - Genoplan 14 M USD
2015-05-12 Juventas Therapeutics Green Cross investment in Series B - Juventas Therapeutics 13.5 M USD
2013-11-20 Argos Therapeutics Green Cross investment in Series E - Argos Therapeutics 17.5 M USD
2009-09-16 PharmAbcine Green Cross investment in Series A - PharmAbcine 6 M USD

Official Site Inspections

http://www.greencross.com Semrush global rank: 2.63 M Semrush visits lastest month: 6.56 K

Unable to get host informations!!!

Loading ...

More informations about "Green Cross" on Search Engine